NCT05045053

Efficacy of Xiidra in Dry Eye Disease After Collagen Cross Linking

Efficacy of Xiidra in the Management Dry Eye Disease After Corneal Collagen Cross Linking

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Benha University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

dry eye disease after corneal collagen cross linking affect ocular function leading to reduced vision, photophobia, glare, halos, and foreign body sensation.

Detailed description

first group of patients were treated with 0.5 % xiidra twice daily and artificial tears for 6 months.Second group treated with artificial tears for 6 months. the treatment starts after corneal collagen cross linking in both groups ,Baseline and post-treatment full ophthalmic examination was done.

Conditions

• Corneal Disease

Interventions

Type	Name	Description
DRUG	Xiidra 5% Ophthalmic Solution	lifitegrast 0.5% ia applied twice daily after corneal collagen cross linking

Timeline

• Start date: 2021-02-01
• Primary completion: 2022-01-01
• Completion: 2022-01-01
• First posted: 2021-09-16
• Last updated: 2021-09-16

Locations

1 site across 1 country: United Arab Emirates